Editing Digitoxin (section)

== Further reading ==
{{refbegin}}
* {{cite journal | vauthors = Johansson S, Lindholm P, Gullbo J, Larsson R, Bohlin L, Claeson P | title = Cytotoxicity of digitoxin and related cardiac glycosides in human tumor cells | journal = Anti-Cancer Drugs | volume = 12 | issue = 5 | pages = 475–83 | date = June 2001 | pmid = 11395576 | doi = 10.1097/00001813-200106000-00009 | s2cid = 19894541 }}
* {{cite journal | vauthors = Hippius M, Humaid B, Sicker T, Hoffmann A, Göttler M, Hasford J | title = Adverse drug reaction monitoring--digitoxin overdosage in the elderly | journal = International Journal of Clinical Pharmacology and Therapeutics | volume = 39 | issue = 8 | pages = 336–43 | date = August 2001 | pmid = 11515708 | doi = 10.5414/cpp39336 }}
* {{cite journal | vauthors = Haux J, Klepp O, Spigset O, Tretli S | title = Digitoxin medication and cancer; case control and internal dose-response studies | journal = BMC Cancer | volume = 1 | pages = 11 | year = 2001 | pmid = 11532201 | pmc = 48150 | doi = 10.1186/1471-2407-1-11 | doi-access = free }}
* {{cite journal | vauthors = Srivastava M, Eidelman O, Zhang J, Paweletz C, Caohuy H, Yang Q, Jacobson KA, Heldman E, Huang W, Jozwik C, Pollard BS, Pollard HB | display-authors = 6 | title = Digitoxin mimics gene therapy with CFTR and suppresses hypersecretion of IL-8 from cystic fibrosis lung epithelial cells | journal = Proceedings of the National Academy of Sciences of the United States of America | volume = 101 | issue = 20 | pages = 7693–8 | date = May 2004 | pmid = 15136726 | pmc = 419668 | doi = 10.1073/pnas.0402030101 | bibcode = 2004PNAS..101.7693S | doi-access = free }}
{{refend}}